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Abstract
Introduction Maintaining arterial blood glucose within tight
limits is beneficial in critically ill patients. Upper and lower limits
of detrimental blood glucose levels must be determined.
Methods In 69 patients with severe traumatic brain injury (TBI),
cerebral metabolism was monitored by assessing changes in
arterial and jugular venous blood at normocarbia (partial arterial
pressure of carbon dioxide (paCO2) 4.4 to 5.6 kPa), normoxia
(partial arterial pressure of oxygen (paO2) 9 to 20 kPa), stable
haematocrit (27 to 36%), brain temperature 35 to 38°C, and
cerebral perfusion pressure (CPP) 70 to 90 mmHg. This
resulted in a total of 43,896 values for glucose uptake, lactate
release, oxygen extraction ratio (OER), carbon dioxide (CO2)
and bicarbonate (HCO3) production, jugular venous oxygen
saturation (SjvO2), oxygen-glucose index (OGI), lactate-glucose
index (LGI) and lactate-oxygen index (LOI). Arterial blood
glucose concentration-dependent influence was determined
retrospectively by assessing changes in these parameters
within pre-defined blood glucose clusters, ranging from less
than 4 to more than 9 mmol/l.
Results Arterial blood glucose significantly influenced signs of
cerebral metabolism reflected by increased cerebral glucose
uptake, decreased cerebral lactate production, reduced oxygen
consumption, negative LGI and decreased cerebral CO2/HCO3
production at arterial blood glucose levels above 6 to 7 mmol/l
compared with lower arterial blood glucose concentrations. At
blood glucose levels more than 8 mmol/l signs of increased
anaerobic glycolysis (OGI less than 6) supervened.
Conclusions Maintaining arterial blood glucose levels between
6 and 8 mmol/l appears superior compared with lower and
higher blood glucose concentrations in terms of stabilised
cerebral metabolism. It appears that arterial blood glucose
values below 6 and above 8 mmol/l should be avoided.
Prospective analysis is required to determine the optimal arterial
blood glucose target in patients suffering from severe TBI.
Introduction
Traumatic brain injury (TBI) induces a plethora of structural
and functional alterations, which contribute to subsequent
deterioration as observed under clinical and experimental con-
ditions. These changes occur in parallel and sequentially. They
are associated with metabolic and energetic disturbances
[1,2], due to impaired perfusion [3]; increased glycolysis [4]
with increased lactate production [5]; regionally altered glu-
cose uptake [6] and impaired glucose metabolism due to
changes in enzymatic and mitochondrial activity [6-10]; func-
tional derangements as observed in cortical spreading depo-
larisations (CSD) [11]; excitotoxicity with disturbed ionic
homeostasis and activated intracellular destructive secondary
cascades [12]; and increased activity of neurons and astro-
cytes [13]. These changes are not only restricted to the area
of impact but are also observed in areas distant to the primary
impact corresponding to contre-coup lesions [14].
Apart from local alterations systemic influences, such as hypo-
tension, hypoxia and anaemia, are detrimental as cerebral oxy-Page 1 of 12
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pathological alterations are aggravated. In addition to hypoten-
sion, hypoxia and anaemia, changes in blood glucose levels
induce additional damage. In this context, hyperglycaemia
induces local acidosis [15,16] and oxidative stress, promotes
oedema formation, impairs nitric oxide-mediated vasodilatation
[17] and activates inflammation as reflected by increased leu-
cocyte infiltration [18]. Hypoglycaemia increases glutamate
release [19], induces metabolic impairment [19], and pro-
motes generation of CSD which, in turn, generates and aggra-
vates exisiting oedema [20].
In contemporary intensive care treatment of patients with
severe TBI secondary brain damage must be avoided. In this
context, hypoglycaemic as well as hyperglycaemic episodes
need to be prevented. Although the upper limit of 10 mmol/l is
well defined because hyperglycaemia exceeding 10 mmol/l is
associated with increased mortality [21], the lower acceptable
limit void of any damaging effect is still unclear. As pointed out
by Strong and colleagues blood glucose levels less than 5
mmol/l increase the development of CSD [20]. In addition,
maintaining blood glucose levels between 3.5 and 6.5 mmol/l
increases frequency of hypoglycaemic episodes [22-27] and
has been shown to induce metabolic impairment in brain-
injured patients [19]. Thus, it appears that arterial blood glu-
cose levels from 5 to less than 10 mmol/l could be more
appropriate in terms of improved metabolic stability. The opti-
mal limits, however, remain to be determined.
Intentionally lowering blood glucose levels and inducing
hypoglycaemia to investigate the impact of different arterial
blood glucose levels on cerebral metabolism following severe
TBI is unethical in humans. In this context, retrospective analy-
sis in evaluating a concentration-dependent impact of different
arterial blood glucose concentrations on cerebral metabolism
is helpful. For this, changes in various parameters of cerebral
metabolism (jugular venous oxygen saturation (SjvO2), oxy-
gen-glucose index (OGI), lactate-oxygen index (LOI), lactate-
glucose index (LGI), arterio-jugular venous glucose and lac-
tate differences) were determined for pre-defined arterial
blood glucose values in a total of 69 patients with severe TBI.
In addition, post hoc analysis of influence of time, different
lesions, side of jugular venous catheter insertion and outcome
was performed.
Materials and methods
Following approval from the local Ethics Committee which
waived the need for written informed consent for this retro-
spective analysis, patient records from a total of 69 patients
treated on the intensive care unit (ICU) of the University Hos-
pital Zuerich, Switzerland, from 2004 to 2006 were reviewed.
All patients were required to have received a jugular venous
catheter with a minimum monitoring time of 24 hours. Patients
with severe injuries anticipated to succumb to their injuries
within the first 24 hours were not considered for the present
analysis. Barbiturates and propofol are known to dose-
dependently suppress neuronal activity and cerebral metabo-
lism [28]. To avoid difficult interpretation of the cerebral meta-
bolic parameters due to differing depth of sedation only
patients subjected to continuous infusion of fentanyl (Sintenyl;
SINTETICA SA Pharmaceuticals, Switzerland) and midazolam
(Dormicum; F. Hoffmann-La Roche AG, Switzerland) were
investigated in the present study.
Standardised treatment protocol
Following severe TBI, intubated and ventilated patients were
treated according to our standardised treatment protocol. Fol-
lowing computed tomography (CT) diagnostic and surgical
interventions including insertion of an intracranial pressure
(ICP) probe (Neurovent, Raumedic AG, 95205 Münchberg,
Germany) patients were transferred to our ICU. Continuous
analgesia and sedation was controlled by bispectral index
electroencephalography (BIS EEG; BIS VISTA, Aspect Medi-
cal Systems, Inc., One Upland Road, Norwood, MA, USA)
tapering drug dosage to maintain a BIS level between 20 and
40. Noradrenaline, dobutamine and volume (crystalloids and
colloids) were administered to maintain cerebral perfusion
pressure (CPP) above 70 mmHg.
Sonographically guided insertion of a jugular bulb catheter in
the larger internal jugular vein was performed within the first
hour after admission to the ICU. In 88% of the investigated
patients the right jugular vein was larger, irrespective of the
type of lesion and predominant location of the brain lesions
(Table 1). Subsequent radiological control using conventional
x-ray of the lateral aspect of the cervical spine and head
revealed the position of the tip of the jugular catheter. When-
ever required the jugular catheter was repositioned with the tip
of the catheter aimed at the caudal aspect of the mastoid proc-
ess to avoid obstructing the jugular bulb and the sigmoid
sinus. Thereafter, arterial and simultaneously drawn jugular
venous blood samples were routinely investigated in four- to
six-hour intervals. This sampling frequency was the same for
every day and every patient until removal of the jugular venous
catheter. Arterial and jugular venous blood gas analyses using
commercially available pre-heparinised syringes (safe PICO
Aspirator, Radiometer, Copenhagen; Radiometer Medical
ApS, Åkadevej 21, DK-2700 Brønshøj, Denmark) were per-
formed using the ABL825 Flex Analyzer (Radiometer Medical
ApS, Åkadevej 21, DK-2700 Brønshøj, Denmark).
Differentiated CPP and ventilation management was guided
by SjvO2 maintaining SjvO2 above 60%. Brain temperature
was maintained between 35 and 36.0°C using cooling blan-
kets or an intravenous cooling system (CoolGard3000; Alsius;
15770 Laguna Canyon Road, Suite 150, Irvine, CA, USA).
Overall, treatment measures were adapted and tapered to pri-
marily maintain ICP below 15 mmHg. Following optimisation of
therapeutic interventions an ICP below 20 mmHg was toler-Page 2 of 12
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Patients received enteral nutrition via gastric or jejunal tube
started within the first 12 hours. Administered calories were
adapted according to indirect calorimetry performed twice
weekly.
Control and standardized management of arterial blood 
glucose concentrations
Arterial blood glucose was controlled in one- to four-hour inter-
vals depending on the actual arterial blood glucose level deter-
mined in the arterial blood gas analysis. Arterial blood glucose
target was set at 3.5 to 6.5 mmol/l based on the findings by
van den Berghe and colleagues [22-24]. Arterial blood glu-
cose was decreased by increasing insulin dose which was
infused continuously. Arterial blood glucose was increased by
decreasing infused insulin and by augmenting enteral nutrition.
Glucose was not routinely infused as performed by van den
Berghe and colleagues [22-24] to reduce the risk of promot-
ing brain oedema formation. Transient glucose infusion was
only considered in cases of severe hypoglycaemia (< 2 mmol/
l) which occurred once in one patient.
Calculated parameters of cerebral metabolism
Arterio-jugularvenous differences
Uptake and release of glucose (glc) and lactate (lac) can be
assessed by calculating corresponding arterio-jugularvenous
differences (AJVD). Although positive values reflect uptake,
negative values unmask cerebral release:
AJVD glc = arterial glc - jugularvenous glc
AJVD lac = arterial lac - jugularvenous lac
Cerebral arterio-jugularvenous difference in oxygen
Arterio-jugularvenous difference in oxygen (avDO2) was calcu-
lated based on the arterial (caO2) and jugular venous oxygen
(cjvO2) content:
avDO2 = caO2 - cjvO2
Arterial and jugular venous oxygen content were calculated
based on haemoglobin (Hb) concentration and oxygen satura-
tion in arterial (SaO2) and jugular venous (SjvO2) blood using
the following equations:
caO2 = (1.34 × Hb × SaO2) + (0.003 × paO2)
cjvO2 = (1.34 × Hb × SjvO2) + (0.003 × pjvO2)
(paO2 = partial arterial oxygen tension; pjvO2 = partial jugular
venous oxygen tension)
Oxygen extraction rate
Oxygen extraction ratio (OER) was calculated based on the
equation:
OER = (caO2 - cjvO2)/caO2, expressed in %.
Oxygen-glucose index
OGI was calculated based on changes in avDO2 and AJVD
glc:
Table 1
Demographic data of 69 patients suffering from severe 
traumatic brain injury.
Parameters Median, range or %
Age (years) 38, 18 to 65
Gender 76% male
Initial GCS 11, 3 to 15
ISS 34, 12 to 54
Isolated TBI 25%
Mortality (%) 26%
Isolated lesions (%) 32%
EDH 2%
SDH 8%
Contusions 12%
tSAH 4%
Oedema 6%
Mixed lesions (%) 68%
Predominant side of brain lesion
Right 22%
Left 11%
Bilateral 67%
Cannulation of right jugular vein
Right-sided lesions 13, 87%
Left-sided lesions 7, 88%
Bilateral lesions 42, 91%
Length of ICU (days)
Survivors 16, 2 to 52
Deceased 10, 2 to 43
Duration of jugular bulb (days)
Survivors 10, 2 to 24
Deceased 7, 2 to 15
EDH = epidural haematoma; GCS = Glasgow Coma Scale; ICU = 
intensive care unit; ISS = injury severity score; SDH = subdural 
haematoma; TBI = traumatic brain injury; tSAH = traumatic 
subarachnoid haemorrhage.Page 3 of 12
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During aerobic glycolysis approximately six molecules of oxy-
gen are used to oxidate one molecule of glucose. Whenever
glucose metabolism exceeds oxygen consumption, the calcu-
lated OGI will be less than 6, thereby reflecting anaerobic gly-
colysis. An OGI of more than 6 indicates aerobic metabolism
of substrates other than glucose, such as lactate.
Lactate-glucose index
LGI was calculated considering changes in AJVD lac and
AJVD glc:
LGI = AJVD lac/AJVD glc
LGI reflects generation of cerebral lactate from glucose.
Increased cerebral lactate production results in negative LGI
values, while positive LGI reflects lactate uptake.
Lactate-oxygen index
LOI was calculated using the following equation:
LOI = AJVD lac/avDO2
LOI can be used as a crude estimate for the extent of cerebral
anaerobic metabolism relative to oxidative metabolism. In this
context, lactate release results in negative LOI although lac-
tate uptake is reflected by a positive LOI.
Arterio-jugularvenous difference in pH
AJVD pH can be used to assess dynamic changes. Less pos-
itive values unmask decreased release of H+ ions, reduced
production of carbon dioxide (CO2) or sustained buffering of
acidosis due to increased release of bicarbonate (HCO3).
AJVD pH = pHa - pHjv
Arterio-jugularvenous difference in pCO2
Negative AJVD partial pressure of CO2 (pCO2) values repre-
sent increased cerebral production of CO2. Less negative
AJVD pCO2 values unmask reduced release of CO2:
AJVD pCO2 = paCO2 - pjvCO2
where paCO2 = partial arterial pressure of carbon dioxide and
pjvCO2 = partial jugular venous pressure of carbon dioxide.
Arterio-jugularvenous difference in HCO3
Dynamic changes in AJVD HCO3 reflect production of HCO3
and intracerebral buffer capacity. In this context, negative
AJVD HCO3 represent increased HCO3 production.
AJVD HCO3 = arterial HCO3 - jugularvenous HCO3
Detailed evaluation
Pre-defined parameters (ICP, CPP, paCO2, parameters of cer-
ebral metabolism) were assessed for different arterial blood
glucose values grouped in 1 mmol/l clusters ranging from less
than 4 to more than 9 mmol/l.
Parameters of cerebral metabolism were investigated under
conditions of normocarbia (paCO2 4.4 to 5.6 kPa), normoxia
(paO2 9 to 20 kPa) and with a haematocrit between 27 and
36%. In addition, only values determined at a temperature
between 35 and 38°C and CPP between 70 and 90 mmHg
were considered. This resulted in a total of 3658 values per
investigated parameter, representing 69% of all recorded time
points. When considering the influence of arterial blood glu-
cose clusters the remaining values per defined cluster were
too small to allow meaningful statistical analysis.
Time dependency was determined by evaluating changes of
the pre-defined paramaters within the arterial blood glucose
clusters during the first, second and third week.
Lesion-dependent influences were assessed by comparing
the pre-defined parameters between lesion subtypes: isolated
lesions versus mixed lesions. A more detailed analysis was not
possible due to a limited number of patients and samples per
lesion subgroup.
Influence of outcome was determined by grouping the pre-
defined parameters according to survivors and non-survivors.
Calculation of frequency of pathological values allow to deter-
mine the impact of different arterial blood glucose clusters on
cerebral brain metabolism. For this, frequency of SjvO2 less
than 60%, OGI less than 6, negative LGI, negative LOI and
negative AJVD lactate levels reflecting increased cerebral oxy-
gen consumption (SjvO2, OER), anaerobic glycolysis (OGI)
and lactate production (LGI, LOI, AJVD lactate) were
assessed in pre-defined arterial blood glucose clusters.
Statistical analysis
Graphical and statistical analysis was performed using Sigma-
Plot 10.0 and SigmaStat 3.5, (Systat Software, Inc. San Jose,
CA., USA) respectively. Changes over time and between
groups were evaluated for statistically significant difference
using the Mann Whitney rank sum test and analysis of variance
(ANOVA) on ranks with post hoc all pairwise multiple compar-
ison procedures (Dunn's test). Differences were rated signifi-
cant with a p < 0.05.
Results
Demographic data
Demographic data of the investigated 69 patients are given in
Table 1. These patients reflect the population of patients with
severe TBI treated at our institution.Page 4 of 12
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Overall, a total of 3658 arterial and corresponding jugular
venous blood gas analyses were performed, resulting in a total
of 43,896 values for the 12 pre-defined parameters (ICP,
CPP, paCO2, SjvO2, OER, LOI, LGI, OGI, AJVD glc, AJVD lac,
AJVD pH, AJVD CO2 and AJVD HCO3).
According to the individual clinical courses, the majority of val-
ues were determined in the first week (52%), followed by 39%
in the second week and 9% in the third week. Thus, the strong-
est statistical power is found during the first two weeks.
Relative frequency of arterial blood glucose values
During weeks one to three, arterial blood glucose concentra-
tions were predominantly measured between 5 and 6 and 6
and 7 mmol/l corresponding to the set blood glucose target of
3.5 to 6.5 mmol/l (Figure 1). There was no significant differ-
ence between weeks one and three.
Glucose-dependent and time-dependent changes
Pre-defined arterial blood glucose clusters resulted in different
numbers of values per cluster for the different parameters: less
than 4 mmol/l = 111; 4 to 5 mmol/l = 543; 5 to 6 mmol/l =
1385; 6 to 7 mmol/l = 1005; 7 to 8 mmol/l = 418; 8 to 9
mmol/l = 134; more than 9 mmol/l = 62 values.
Increasing arterial blood glucose was associated with a signif-
icantly increased cerebral glucose uptake reflected by a more
positive AJVD glc (Figure 2). In parallel, lactate release was
decreased revealed by a less negative AJVD lac approaching
positive values (Figure 2). Significant increases were
observed at arterial blood glucose levels between 8 and 9
mmol/l compared with arterial blood glucose less than 8
mmol/l. There were no significant differences between the dif-
ferent weeks (weeks 1, 2 and 3) (data not shown).
OER was significantly decreased reaching lowest values at
blood glucose more than 8 mmol/l (Figure 3). Changes in OER
were reflected by increased SjvO2 levels, respectively, reach-
ing highest values at blood glucose more than 8 mmol/l (Fig-
ure 3).
Calculated OGI was significantly decreased with increasing
arterial blood glucose levels exceeding 8 mmol/l (Figure 4).
There was no difference over time (data not shown).
Calculated LOI showed a trend towards elevated values with
increasing arterial blood glucose levels. There was no differ-
ence over time (data not shown).
Calculated LGI approached positive values and was signifi-
cantly increased with higher arterial blood glucose concentra-
tions exceeding 8 mmol/l (Figure 5). There was no difference
over time (data not shown).
Figure 1
Changes in relative frequency of arterial blood glucose levels deter-mined in pre-defin d blood glucose clusters for the first three we ks in a total of 69 patients
mined in pre-defined blood glucose clusters for the first three weeks in 
a total of 69 patients. The majority of arterial blood glucose values were 
found between 5 and 6 mmol/l and 6 and 7 mmol/l, which was similar 
at all investigated time points.
Figure 2
Changes in calculated arterial jugular venous differences in glucose (grey box plots) and lactat  (white box plots) for p -defined arterial blood glucose l s rs
(grey box plots) and lactate (white box plots) for pre-defined arterial 
blood glucose clusters. Compared with low arterial blood glucose lev-
els cerebral glucose uptake was significantly increased although cere-
bral lactate production was significantly decreased at arterial blood 
glucose concentrations between 7.5 and 8.5 mmol/l (*p < 0.001; anal-
ysis of variance (ANOVA) on ranks and post hoc Dunn's test). Cerebral 
uptake is reflected by positive values although cerebral release is 
unmasked by negative values. AJVD = arterio-jugularvenous difference; 
glc = glucose; lac = lactate.Page 5 of 12
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cantly reduced with arterial blood glucose exceeding 6 mmol/
l (Figures 6 and 7). This was reflected by a smaller AJVD pH
(data not shown).
With elevated arterial blood glucose levels, frequency of
increased cerebral oxygen consumption (SjvO2 less than
60%) and cerebral lactate production (negative LGI values)
were reduced (Figure 8). Rate of anaerobic glycolysis (OGI
less than 6), however, was increased at higher arterial blood
glucose levels (Figure 8).
Figure 3
Changes in jugular venous oxygen saturation (SjvO2) (white box plots) within pre-defined arterial blood glucose clusters
within pre-defined arterial blood glucose clusters. Changes in SjvO2 
were significantly increased at arterial blood glucose levels above 8 
mmol/l compared with lower arterial blood glucose levels. *p < 0.001; 
analysis of variance (ANOVA) on ranks and post hoc Dunn's test. Cal-
culated oxygen extraction ratio (OER) (grey box plots) within pre-
defined arterial blood glucose clusters was significantly decreased at 
arterial blood glucose levels above 8 mmol/l compared with lower arte-
rial blood glucose levels. *p < 0.001; ANOVA on ranks and post hoc 
Dunn's test.
Figure 4
Oxygen-glucose index (OGI) was significantly increased compared with normal values
with normal values. This is reflected by the straight line at 6. With 
increasing arterial blood glucose concentrations OGI was significantly 
decreased compared with lower arterial blood glucose levels. *p < 
0.001; analysis of variance (ANOVA) on ranks and post hoc Dunn's 
test.
Figure 5
Lactate-glucose-index (LGI) was significantly decreased compared with normal values
with normal values. With arterial blood glucose levels exceeding 8 
mmol/l, LGI was significantly increased reaching normal values. *p < 
0.001; analysis of variance (ANOVA) on ranks and post hoc Dunn's 
test.
Figure 6
Calculated arterial jugular venous difference in partial pressure of car-bon dioxide (AJVDpCO2)
bon dioxide (AJVDpCO2). Values were significantly increased with arte-
rial blood glucose concentrations exceeding 6 mmol/l compared with 
low arterial blood glucose levels. *p < 0.001; analysis of variance 
(ANOVA) on ranks and post hoc Dunn's test.Page 6 of 12
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values (data not shown).
Lesion-dependent changes
Pre-defined cerebral metabolic parameters, as well as ICP and
CPP, were similar in patients with isolated lesions compared
with mixed lesions (data not shown). There were no differ-
ences in type and extent of therapeutic measures.
Side-dependent changes
In the majority of the investigated patients (62 of 69 patients)
the jugular venous catheter was inserted in the right jugular
vein, irrespective of the type of lesion and the predominant
side of the brain lesions (Table 1) (right-sided brain lesions: 13
of 15 patients; left-sided brain lesions: 7 of 8 patients; bilateral
brain lesions: 42 of 46 patients). In the remaining seven
patients, the left jugular vein was canulated. There was no dif-
ference in brain metabolism between left-sided or right-sided
cannulation. However, the low number of patients and uneven
distribution within the different brain lesions did not allow sta-
tistical analysis.
Outcome-dependent changes
Investigated metabolic parameters could not differentiate non-
surviving patients from surviving patients (data not shown).
Discussion
Bed-side analysis of changes in arterial and jugular venous dif-
ferences and their derived indices of cerebral metabolism dif-
ferentiated less favourable from more favourable arterial blood
glucose concentrations. Overall, cerebral metabolism
appeared more stable as judged by increased glucose uptake,
reduced cerebral lactate, CO2 and HCO3 production/release,
elevated SjvO2, decreased OER, increased LOI and elevated
LGI with arterial blood glucose levels between 8 and 9 mmol/l.
Limitations of the study
The retrospective nature of the present analysis does not allow
the clear definition of the dynamic processes induced by spe-
cific arterial blood glucose concentrations or induced thera-
peutic interventions because investigated changes were taken
from the pooled data obtained in 69 patients with severe TBI.
These pooled data consist of arterial and jugular venous blood
samples which were drawn at fixed time intervals predomi-
nantly ranging from four to six hours. These time intervals were
independent of changes in arterial blood glucose values which
might have occurred between these sampling intervals. A pro-
spective study designed to specifically investigate the impact
of dynamic changes by assessing alterations of cerebral met-
abolic parameters at pre-defined changes in arterial blood glu-
cose levels is required to address this issue.
Calculated differences and indices of cerebral metabolism are
widely accepted to gain insight in otherwise occult changes
within the brain [7,29-33]. However, the low temporal and spa-
Figure 7
Calculated arterial jugular venous difference in bicarbonate (AJVDHCO3-)
(AJVDHCO3-). Values were significantly increased with arterial blood 
glucose concentrations exceeding 8 mmol/l compared with low arterial 
blood glucose levels. *p < 0.001; analysis of variance (ANOVA) on 
ranks and post hoc Dunn's test.
Figure 8
Calculation of frequency of pathological values within pre-defined arte-rial blood glucose clusters
rial blood glucose clusters. Values are given for increased cerebral oxy-
gen consumption (jugular venous oxygen saturation (SjvO2) less than 
60%), sustained anaerobic glycolysis (oxygen-glucose index (OGI) less 
than 6), and increased cerebral lactate production (negative lactate-
glucose index (LGI)). With elevated arterial blood glucose the rate of 
increased cerebral oxygen consumption (SjvO2 less than 60%) was 
reduced which coincided with decreased rate of increased cerebral 
lactate production (negative LGI). However, frequency of anaerobic gly-
colysis (OGI less than 6) was increased.Page 7 of 12
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changes between the individual blood sampling time points
and influences of injured versus non-injured or lesser injured
tissue because blood samples were drawn in four- to six-hour
intervals and jugular venous blood reflects global rather than
local intracerebral changes. In this context it has been shown
that SjvO2 only partially reflects pathological intracerebral
alterations [34] which show a strong regional heterogeneity
within peri-lesional tissue compared with lesions [35].
As observed in healthy volunteers magnetic resonance venog-
raphy revealed a significant asymmetry in the venous blood
flow from the superior sagittal sinus flow to one transverse
sinus in 84% of the volunteers [36]. Based on a theoretical
model this is accepted to result in an asymmetry in jugular
venous oxygen saturation measurements in patients with a
supratentorial lesion [36]. As shown by Metz and colleagues
[37], monitoring of cerebral metabolism using bilateral jugular
venous catheters is superior to the unilateral approach when
searching for signs of posttraumatic cerebral ischaemia due to
insufficient CPP and hyperventilation. Nevertheless 87% of
ischaemic events were detected when monitoring ipsilateral to
the predominant lesion or the side with the predominant jugu-
lar venous outflow (in patients with diffuse brain injury). Thus,
we can expect to unmask pathological alterations in the major-
ity of our patients. The scientific superiority of bilateral cannu-
lation of the jugular vein is off-set by the clinically relevant
increased risk of bilateral thrombosis formation, which could
result in increased ICP because of reduced venous outflow.
Although microdialysis [1,2,5,16,19,38,39], positron emission
tomography (PET) [4-6,39,40], and single photon emission
computed tomography (SPECT) [41] allow more detailed
insight, these techniques are also confronted with specific lim-
itations, such as high costs, decreased regional and temporal
resolution, respectively.
Continuous arterial and jugular venous blood sampling with
subsequent analysis of metabolic parameters would be helpful
as described under experimental conditions [42]. However,
appropriate techniques have not yet been developed for the
clinical application of this. Until then, easy and cheap analysis
of intermittently drawn blood gases which is an integral part of
contemporary intensive care treatment of critically ill patients
is the only feasible approach applicable in any specialised
ICU.
Glucose and cerebral metabolism
Glucose is the predominant fuel for energy consuming proc-
esses within the brain [32]. Glucose is mainly used by the
Na+/K+ ATPase which is indispensable to maintain membrane
stability and prevent functional, as well as structural, cell dam-
age [43]. Various endothelial, glial and neuronal glucose trans-
porters with different transport characteristics guarantee
sufficient glucose transport across the blood brain barrier
(GLUT1) as well as glial (GLUT1, 5) and neuronal (GLUT3, 4,
6, 8) glucose uptake [13,44]. In this context, the neuronal
GLUT3 exhibits a lower Km (Michaelis constant) and a higher
Vmax (maximal transport velocity) compared with the other glu-
cose transporters: Km = 1.4 to 2.8 mmol/l [13,44], Vmax = 5 to
34.6 nM/106 cells/minute [13], resulting in a significantly
higher affinity and transport capacity compared with GLUT1,
for example. These characteristics, in turn, guarantee ade-
quate neuronal glucose utilisation under conditions of
decreased glucose supply. This is important because the
ambient glucose levels within the neuronal environment is
rather low ranging from 1 to 2 mmol/l compared with normal
blood glucose levels between 5 and 6 mmol/l. Thus, any
decrease in arterial blood glucose in conjunction with impaired
endothelial glucose transport due to reduced GLUT1 expres-
sion will endanger neuronal function and viability.
Following TBI, increased GLUT3 expression [45] guarantees
neuronal glucose uptake although decreased GLUT1 expres-
sion [46], as found under experimental conditions, limits
endothelial glucose transport. Decreased GLUT1 expression
in conjunction with reduced blood glucose levels result in a
concentration-dependent decrease in glucose flux, which is
mostly sustained at blood glucose levels below 3 mmol/l [47].
Under clinical conditions it is unclear which changes in pres-
ence and function of the different GLUT subtypes are preva-
lent. The arterial blood glucose concentration-dependent
cerebral uptake of glucose, as seen in the present study, sug-
gests that arterial blood glucose concentrations maintained
below the optimal Km of the endothelial GLUT1, that is less
than 8 mmol/l [13,44] will result in insufficient supply. This can
be overcome by maintaining arterial blood glucose levels at
about 8 mmol/l as reflected by increased metabolic stability.
This is in line with findings showing the impact of decreased
glucose supply on posttraumatic functional disturbances after
TBI in terms of induced CSD [20], increased extracellular
glutamate and elevated lactate/pyruvate ratio [19]. As pointed
out by Vespa and colleagues, cerebral oxygen consumption
was decreased in patients with higher blood glucose concen-
trations (120 to 150 versus 90 to 120 mg/dl) [19]. This is also
seen in the present patients. These findings strongly suggest
that activation of glucose transporter systems influence cere-
bral oxygen consumption. As shown by Abate and colleagues
[48] increased cerebral glucose consumption is associated
with elevated OER, although low cerebral glucose consump-
tion results in decreased OER. Thus, the present data suggest
that metabolic instability, which can also occur independently
from cerebral ischaemia [2], can be influenced substantially by
changing arterial blood glucose levels.
Classically, OER has always been discussed in the context of
altered cerebral perfusion due to hypotension and hyperventi-
lation [49] as increased OER reflects insufficient cerebral per-
fusion. The present findings, in conjunction with previouslyPage 8 of 12
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metabolism substantially influence OER. Increased oxygen
consumption resulting from energetic impairment (lactate pro-
duction, elevated lactate/pyruvate ratio) and neuronal excita-
tion due to sustained glutamate release could increase
cerebral perfusion to correct this oxygen and energy deficit.
This, however, requires an intact coupling between metabo-
lism and perfusion [50], which is known to be disturbed after
severe TBI [34] and during sedation/anaesthesia [51].
Based on the facts that CPP was maintained above 70 mmHg
and sedation was unchanged at all investigated time points of
analysis – assuming sufficient regional cerebral perfusion and
stable pharmacological coma – we speculate that metabolic
impairment due to low arterial blood glucose levels was the
driving force for the observed increase in OER at arterial blood
glucose values less than 7 mmol/l coinciding with increased
lactate and CO2 production, and lower LGI. However, the
present data do not allow for the reliable differentiation of
whether metabolic impairment might aggravate oedema for-
mation resulting in microcirculatory deterioration which, in
turn, increases OER. It also remains unclear whether the
increased CO2 production reflected by the negative AJVD
pCO2 counteracts perfusion, metabolism mismatch or contrib-
utes to ongoing metabolic impairment due to vessel dilation
and subsequent sustained brain swelling with compression of
the microcirculation. Further analysis including assessment of
cerebral perfusion is warranted to determine the functional
impact of the metabolic changes observed in the present ret-
rospective analysis.
Signs of tissue acidosis and regulation of cerebral 
metabolism
Severe TBI induces brain tissue acidosis reflected by signifi-
cantly decreased brain tissue pH inversely correlated with ele-
vated brain lactate and pCO2 during the first posttraumatic
day [52]. Brain pH can either be determined directly by insert-
ing specialised probes to measure pH or indirectly by measur-
ing tissue pCO2 and lactate. In addition, assessing changes in
arterio-jugular venous differences in pCO2 as reported by
Chieregato and colleagues [33] or HCO3- as performed in the
present study can be used to indirectly determine changes in
brain pH. Apart from insufficient cerebral perfusion and cere-
bral oxygenation [52] concomitant hyperglycaemia has also
been shown to aggravate TBI- and ischaemia-induced brain
tissue acidosis [53,54]. Sustained cerebral CO2 and HCO3-
production due to increased metabolism reflect underlying
activation of various transporter systems and regulatory mech-
anisms. In this context, cerebral pH is regulated by Na+/H+
exchange, Na+-driven Cl-/HCO3- exchange, Na+-HCO3-
cotransport and passive Cl-/HCO3- exchange [55].
As unmasked by the present study, low arterial blood glucose
levels less than 8 mmol/l are also associated with sustained
CO2, HCO3- and lactate production suggesting that inade-
quate glucose supply activates various transporter systems
such as the Na+/K+ATPase and glucose transporters to meet
increased metabolic and energetic demands resulting from,
for example, sustained hypoglycaemia-induced glutamate
release [19] and subsequent glutamate-mediated increased
cerebral glucose consumption [56].
Glucose and secondary cerebral damage
Any decrease in arterial glucose will impair cerebral glucose-
dependent pathways, thereby resulting in disturbed metabo-
lism as reflected by increased lactate/pyruvate ratio [19]. This,
in turn, can induce excitotoxic damage resulting in increased
extracellular glutamate levels [19]. As shown by Shulman and
colleagues [57] approximately 80% of cortical glucose con-
sumption (in the rat brain) is driven by glutamate cycling. Thus,
glutamate release due to reduced arterial blood glucose levels
[19] increases cerebral glucose utilisation, which cannot be
met if arterial blood glucose remains low. This is of importance
whenever glucose uptake, glucose metabolism, enzymatic
function, local perfusion and local diffusion processes are dis-
turbed. Together with these alterations reduced blood glucose
can aggravate underlying brain damage. In this context, a
decrease in blood glucose levels below 8 mmol/l was associ-
ated with a significant elevation in peri-ischaemic cortical
depolarisations [58]. This coincided with metabolic impair-
ment reflected by an increase in extracellular cerebral lactate
and decrease in extracellular glucose measured by microdial-
ysis [58]. The occurrence of cortical depolarisations was dra-
matically increased when blood glucose levels dropped below
6 mmol/l [58,59]. Consequently, induction of CSD known to
promote secondary damage can be avoided by maintaining
arterial blood glucose above 5 mmol/l. As suggested by the
present findings arterial blood glucose ranging from 7 to 9
mmol/l appear more beneficial in terms of improved metabolic
stability.
Which arterial blood glucose concentration is optimal 
after severe TBI?
Under conditions of relative cerebral glucose insufficiency due
to increased cerebral glycolysis or absolute glucose insuffi-
ciency caused by systemic hypoglycemia, the brain can
metabolize lactate, pyruvate, and keton bodies [13,32]. How-
ever, lactate metabolism is less efficient than glycolysis and
mitochondrial oxidative phosphorylation which result in higher
ATP production compared with lactate degradation. Lactate
metabolism includes energy-consuming shuttling processes
to transport lactate from astrocytes to neurons for subsequent
generation of pyruvate via lactate dehydrogenase and further
processing in the citric acid cycle and mitochondrial respira-
tory chain [13]. Although cerebral glycogen stores have been
shown to exceed arterial blood glucose levels by three- to four-
fold during euglycaemia in healthy controls [60], reflecting an
additional valuable energetic reserve, it is unclear to what
extent and for which duration glycogenolysis can fuel energy-
requiring processes under pathological conditions. As sug-Page 9 of 12
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content following experimental TBI could serve as an endog-
enous source of metabolic energy [61]. Thus, a decrease in
arterial blood glucose should trigger glycogenolysis to main-
tain extracellular glucose concentrations and avoid metabolic
impairment. However, this does not seem to occur under clin-
ical conditions because decreased blood glucose resulted in
a significant reduction in extracellular glucose concentrations
determined by microdialysis in TBI and epileptic patients
[19,62]. Hypoglycaemia-induced impaired cerebral metabo-
lism in terms of lactate production, as observed in the present
study, and increased lactate/pyruvate ratio [19] reflects a sub-
ordinated importance of glycogen under these specific condi-
tions to prevent energetic deterioration. Consequently,
sufficient cerebral glucose supply must be guaranteed to pre-
vent avoidable secondary brain damage.
As suggested by the present retrospective analysis, optimal
arterial blood glucose levels range from 6 to 8 mmol/l. With
arterial blood glucose levels exceeding 8 mmol/l differentiated
metabolic pathways appear to be activated as reflected by
decreased rate of increased oxygen consumption and
reduced frequency of increased cerebral lactate production.
At the same time, however, anaerobic glycolysis reflected by
OGI values less than 6 was increased. Apart from anaerobic
metabolism, which implies underlying ischaemia or hypoxia, it
could be possible that non-oxidative metabolism resulting from
mitochondrial damage and impaired oxidative phosphorylation
despite sufficient perfusion and oxygen supply accounts for
the observed decrease in OGI. This is in line with the patho-
physiological mechanism of destructive influence of elevated
arterial blood glucose levels on mitochondria due to hypergly-
caemia-induced production of free oxygen radicals with sub-
sequent impairment of oxidative phosphorylation as discussed
by van den Berghe and colleagues [22-24].
Taken together, arterial blood glucose levels between 6 and 8
mmol/l could be an appropriate range for patients suffering
from severe TBI.
Conclusions
To avoid cerebral metabolic impairment and prevent second-
ary brain damage adequate blood glucose levels must be
induced and maintained during the intensive care phase.
Although substantial and reproducible evidence exists to
avoid arterial blood glucose levels exceeding 10 mmol/l, the
optimal lower blood glucose level is less clear. The present
results strongly suggest that arterial blood glucose concentra-
tions less than 6 mmol/l should be avoided and that optimal
cerebral metabolic stability is found at arterial blood glucose
levels of about 8 mmol/l as reflected by increased cerebral glu-
cose uptake, decreased cerebral lactate production,
increased SjvO2, as well as decreased cerebral oxygen extrac-
tion, CO2 and HCO3 production. The increased frequency of
reduced OGI below 6 at arterial blood glucose levels exceed-
ing 8 mmol/l appears to delineate the upper limit of acceptable
arterial blood glucose levels. Prospective studies are needed
to define the optimal arterial blood glucose target in patients
with severe TBI.
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